Literature DB >> 27151989

Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.

Roberta La Starza1, Gianluca Barba1, Sofie Demeyer2, Valentina Pierini1, Danika Di Giacomo1, Valentina Gianfelici3, Claire Schwab4, Caterina Matteucci1, Carmen Vicente2, Jan Cools2, Monica Messina3, Barbara Crescenzi1, Sabina Chiaretti3, Robin Foà3, Giuseppe Basso5, Christine J Harrison4, Cristina Mecucci6.   

Abstract

Recurrent deletions of the long arm of chromosome 5 were detected in 23/200 cases of T-cell acute lymphoblastic leukemia. Genomic studies identified two types of deletions: interstitial and terminal. Interstitial 5q deletions, found in five cases, were present in both adults and children with a female predominance (chi-square, P=0.012). Interestingly, these cases resembled immature/early T-cell precursor acute lymphoblastic leukemia showing significant down-regulation of five out of the ten top differentially expressed genes in this leukemia group, including TCF7 which maps within the 5q31 common deleted region. Mutations of genes known to be associated with immature/early T-cell precursor acute lymphoblastic leukemia, i.e. WT1, ETV6, JAK1, JAK3, and RUNX1, were present, while CDKN2A/B deletions/mutations were never detected. All patients had relapsed/resistant disease and blasts showed an early differentiation arrest with expression of myeloid markers. Terminal 5q deletions, found in 18 of patients, were more prevalent in adults (chi-square, P=0.010) and defined a subgroup of HOXA-positive T-cell acute lymphoblastic leukemia characterized by 130 up- and 197 down-regulated genes. Down-regulated genes included TRIM41, ZFP62, MAPK9, MGAT1, and CNOT6, all mapping within the 1.4 Mb common deleted region at 5q35.3. Of interest, besides CNOT6 down-regulation, these cases also showed low BTG1 expression and a high incidence of CNOT3 mutations, suggesting that the CCR4-NOT complex plays a crucial role in the pathogenesis of HOXA-positive T-cell acute lymphoblastic leukemia with terminal 5q deletions. In conclusion, interstitial and terminal 5q deletions are recurrent genomic losses identifying distinct subtypes of T-cell acute lymphoblastic leukemia. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27151989      PMCID: PMC4967574          DOI: 10.3324/haematol.2016.143875

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  49 in total

1.  Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).

Authors:  F Lai; L A Godley; J Joslin; A A Fernald; J Liu; R Espinosa; N Zhao; L Pamintuan; B G Till; R A Larson; Z Qian; M M Le Beau
Journal:  Genomics       Date:  2001-01-15       Impact factor: 5.736

2.  Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia.

Authors:  S Faderl; C Gidel; H M Kantarjian; T Manshouri; M Keating; M Albitar
Journal:  Leuk Res       Date:  2001-01       Impact factor: 3.156

Review 3.  Ccr4-Not complex: the control freak of eukaryotic cells.

Authors:  Jason E Miller; Joseph C Reese
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-03-15       Impact factor: 8.250

4.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

5.  Impaired myelopoiesis in mice devoid of interferon regulatory factor 1.

Authors:  U Testa; E Stellacci; E Pelosi; P Sestili; M Venditti; R Orsatti; A Fragale; E Petrucci; L Pasquini; F Belardelli; L Gabriele; A Battistini
Journal:  Leukemia       Date:  2004-11       Impact factor: 11.528

6.  Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

Authors:  Kheira Beldjord; Sylvie Chevret; Vahid Asnafi; Françoise Huguet; Marie-Laure Boulland; Thibaut Leguay; Xavier Thomas; Jean-Michel Cayuela; Nathalie Grardel; Yves Chalandon; Nicolas Boissel; Beat Schaefer; Eric Delabesse; Hélène Cavé; Patrice Chevallier; Agnès Buzyn; Thierry Fest; Oumedaly Reman; Jean-Paul Vernant; Véronique Lhéritier; Marie C Béné; Marina Lafage; Elizabeth Macintyre; Norbert Ifrah; Hervé Dombret
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

7.  An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

Authors:  Jonathan Bond; Tony Marchand; Aurore Touzart; Agata Cieslak; Amélie Trinquand; Laurent Sutton; Isabelle Radford-Weiss; Ludovic Lhermitte; Salvatore Spicuglia; Hervé Dombret; Elizabeth Macintyre; Norbert Ifrah; Jean-François Hamel; Vahid Asnafi
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

8.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

9.  Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.

Authors:  John M Joslin; Anthony A Fernald; Thelma R Tennant; Elizabeth M Davis; Scott C Kogan; John Anastasi; John D Crispino; Michelle M Le Beau
Journal:  Blood       Date:  2007-04-09       Impact factor: 22.113

10.  Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.

Authors:  Stephen Q Wong; Andreas Behren; Victoria J Mar; Katherine Woods; Jason Li; Claire Martin; Karen E Sheppard; Rory Wolfe; John Kelly; Jonathan Cebon; Alexander Dobrovic; Grant A McArthur
Journal:  Oncotarget       Date:  2015-01-20
View more
  8 in total

1.  Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.

Authors:  Matteo Marchesini; Andrea Gherli; Anna Montanaro; Laura Patrizi; Claudia Sorrentino; Luca Pagliaro; Chiara Rompietti; Samuel Kitara; Sabine Heit; Claus E Olesen; Jesper V Møller; Monia Savi; Leonardo Bocchi; Rocchina Vilella; Federica Rizzi; Marilena Baglione; Giorgia Rastelli; Caterina Loiacono; Roberta La Starza; Cristina Mecucci; Kimberly Stegmaier; Franco Aversa; Donatella Stilli; Anne-Marie Lund Winther; Paolo Sportoletti; Maike Bublitz; William Dalby-Brown; Giovanni Roti
Journal:  Cell Chem Biol       Date:  2020-05-07       Impact factor: 8.116

Review 2.  T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.

Authors:  Valentina Cordo'; Jordy C G van der Zwet; Kirsten Canté-Barrett; Rob Pieters; Jules P P Meijerink
Journal:  Blood Cancer Discov       Date:  2020-11-24

3.  14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.

Authors:  Danika Di Giacomo; Roberta La Starza; Paolo Gorello; Fabrizia Pellanera; Zeynep Kalender Atak; Kim De Keersmaecker; Valentina Pierini; Christine J Harrison; Silvia Arniani; Martina Moretti; Nicoletta Testoni; Giovanna De Santis; Giovanni Roti; Caterina Matteucci; Renato Bassan; Peter Vandenberghe; Stein Aerts; Jan Cools; Beat Bornhauser; Jean-Pierre Bourquin; Rocco Piazza; Cristina Mecucci
Journal:  Blood       Date:  2021-09-02       Impact factor: 22.113

Review 4.  Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.

Authors:  Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

5.  MEF2C expression, but not absence of bi-allelic deletion of TCR gamma chains (ABD), is a predictor of patient outcome in Indian T-acute lymphoblastic leukemia.

Authors:  Jay Singh; Rajive Kumar; Deepak Verma; Nishi Rajput; Jayanth Kumar Palanichamy; Gunjan Sharma; Sameer Bakhshi; Atul Sharma; Deepam Pushpam; Rachna Seth; Amar Ranjan; Pranay Tanwar; Archna Singh; Mohit Arora; Sarita Kumari; Anita Chopra
Journal:  Am J Blood Res       Date:  2020-10-15

Review 6.  The Regulatory Properties of the Ccr4-Not Complex.

Authors:  Nafiseh Chalabi Hagkarim; Roger J Grand
Journal:  Cells       Date:  2020-10-29       Impact factor: 6.600

Review 7.  Nucleophosmin in Its Interaction with Ligands.

Authors:  Ilaria Cela; Adele Di Matteo; Luca Federici
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

8.  The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models.

Authors:  Carmen Vicente; Rocco Stirparo; Sofie Demeyer; Charles E de Bock; Olga Gielen; Mardelle Atkins; Jiekun Yan; Georg Halder; Bassem A Hassan; Jan Cools
Journal:  J Hematol Oncol       Date:  2018-08-25       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.